AMPHENOL ($APH) posted quarterly earnings results for Q1 2026 on Wednesday, April 29th. The company reported earnings of $1.06 per share, beating estimates of $0.95 by $0.11. The company also reported revenue of $7,620,100,000, beating estimates of $7,157,200,501 by $462,899,499.
You can see Quiver Quantitative's $APH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMPHENOL Insider Trading Activity
AMPHENOL insiders have traded $APH stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $APH stock by insiders over the last 6 months:
- CRAIG A LAMPO (SR VP & CFO) has made 0 purchases and 2 sales selling 298,076 shares for an estimated $42,697,133.
- MICHAEL R. IVAS (VP & Corporate Controller) has made 0 purchases and 2 sales selling 240,000 shares for an estimated $33,762,588.
- WILLIAM J DOHERTY (President, CS Division) has made 0 purchases and 2 sales selling 160,000 shares for an estimated $22,643,160.
- PETER STRAUB (President, ISS Division) sold 132,000 shares for an estimated $18,722,840
- DAVID M SILVERMAN (Senior VP, Human Resources) sold 120,000 shares for an estimated $16,940,472
- LANCE E D'AMICO (Sr. VP, Secretary & GenCounsel) sold 120,000 shares for an estimated $16,801,548
- ROBERT LIVINGSTON purchased 10,000 shares for an estimated $1,285,080
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
AMPHENOL Hedge Fund Activity
We have seen 1,006 institutional investors add shares of AMPHENOL stock to their portfolio, and 890 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP added 75,964,718 shares (+9435.8%) to their portfolio in Q4 2025, for an estimated $10,265,871,990
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 23,934,785 shares (-74.1%) from their portfolio in Q4 2025, for an estimated $3,234,546,844
- JPMORGAN CHASE & CO added 17,391,036 shares (+102.7%) to their portfolio in Q4 2025, for an estimated $2,350,224,605
- FMR LLC removed 13,395,833 shares (-13.4%) from their portfolio in Q4 2025, for an estimated $1,810,312,871
- JENNISON ASSOCIATES LLC added 7,930,532 shares (+340.8%) to their portfolio in Q4 2025, for an estimated $1,071,732,094
- BANK OF NEW YORK MELLON CORP removed 6,290,275 shares (-26.2%) from their portfolio in Q4 2025, for an estimated $850,067,763
- PRICE T ROWE ASSOCIATES INC /MD/ removed 6,148,762 shares (-14.0%) from their portfolio in Q4 2025, for an estimated $830,943,696
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
AMPHENOL Analyst Ratings
Wall Street analysts have issued reports on $APH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/12/2026
To track analyst ratings and price targets for AMPHENOL, check out Quiver Quantitative's $APH forecast page.
AMPHENOL Price Targets
Multiple analysts have issued price targets for $APH recently. We have seen 6 analysts offer price targets for $APH in the last 6 months, with a median target of $177.5.
Here are some recent targets:
- Samik Chatterjee from JP Morgan set a target price of $190.0 on 04/16/2026
- Joseph Spak from UBS set a target price of $170.0 on 04/14/2026
- Stephen Volkmann from Jefferies set a target price of $145.0 on 03/31/2026
- Guy Hardwick from Barclays set a target price of $175.0 on 01/29/2026
- Asiya Merchant from Citigroup set a target price of $180.0 on 01/29/2026
- William Stein from Truist Securities set a target price of $180.0 on 12/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
